Association between gestational hypnotic benzodiazepine receptor agonists exposure and adverse pregnancy outcomes: a systematic review and meta-analysis

被引:0
|
作者
Wang, Xinyuan [1 ]
Xu, Jun [2 ]
Mo, Yifei [1 ]
Wang, Linrun [3 ]
机构
[1] First Peoples Hosp Yuhang Dist, Dept Pharm, 1260 Kangliang St, Liangzhu St, Hangzhou 311113, Zhejiang, Peoples R China
[2] Community Hlth Serv Ctr Liangzhu St, Dept Pharm, Liangzhu St, 151 Yucong Rd, Hangzhou 311113, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Pharm, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
关键词
Hypnotics; Anxiolytics; Sedatives; Congenital malformations; Preterm birth; Adverse pregnancy outcomes; DRUGS; BIRTH; RISK;
D O I
10.1007/s00737-024-01516-3
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
ObjectiveHypnotic benzodiazepine receptor agonists (HBRA) are frequently prescribed in pregnancy but little is known about their effects on pregnancy outcomes. Herein, we systematically reviewed the evidence on the effects of HBRA exposure during pregnancy and risk of preterm birth (PTB), small for gestational age (SGA), birth defects, and low birth weight (LBW).MethodsWe reviewed the databases of PubMed, CENTRAL, Embase, Scopus, and Web of Science from the earliest possible date to 17th May 2024 and included all studies examining adverse pregnancy outcomes with gestational exposure to HBRA.ResultsNine studies were included. Meta-analysis showed that HBRA exposure led to a significant increase in the risk of PTB (OR: 1.28 95% CI: 1.05, 1.56 I2 = 73%), SGA (OR: 1.24 95% CI: 1.18, 1.30 I2 = 0%), and LBW (OR: 1.51 95% CI: 1.27, 1.78 I2 = 26%). We noted no significant association between HBRA exposure in pregnancy and subsequent birth defects (OR: 0.90 95% CI: 0.63, 1.28 I2 = 56%). Subgroup analysis based on exposure time, type of HBRA, method of assessment of exposure, control of psychiatric diagnosis, and psychotropic drugs altered the results of PTB and SGA but not for birth defects.ConclusionHBRA exposure during pregnancy may lead to a small but significant increase in the risk of PTB, SGA, and LBW. HBRA is not associated with an increased risk of birth defects. There are several limitations of current evidence especially with regards to adjustment for psychiatric illness and co-mediations which need to be overcome by future studies. center dot HBRA exposure during pregnancy may lead to a small but significant increase in the risk of PTB, SGA, and LBW.center dot HBRA is not associated with an increased risk of birth defects.center dot There are several limitations of current evidence especially with regards to adjustment for psychiatric illness and co-mediations which need to be overcome by future studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Hypnotic benzodiazepine receptor agonist exposure during pregnancy and the risk of congenital malformations and other adverse pregnancy outcomes: A systematic review and meta-analysis
    Grigoriadis, Sophie
    Alibrahim, Aseel
    Mansfield, Joanna K.
    Sullovey, Amanda
    Robinson, Gail Erlick
    ACTA PSYCHIATRICA SCANDINAVICA, 2022, 146 (04) : 312 - 324
  • [2] The association between mercury exposure during pregnancy and adverse birth outcomes: A systematic review and meta-analysis
    Pan, Kai
    Xu, Jie
    Li, Feng
    Yu, Huawen
    Yu, Jie
    ENVIRONMENTAL RESEARCH, 2025, 264
  • [3] Pregnancy and Delivery Outcomes Following Benzodiazepine Exposure: A Systematic Review and Meta-analysis
    Grigoriadis, Sophie
    Graves, Lisa
    Peer, Miki
    Mamisashvili, Lana
    Ruthirakuhan, Myuri
    Chan, Parco
    Hennawy, Mirna
    Parikh, Supriya
    Vigod, Simone Natalie
    Dennis, Cindy-Lee
    Steiner, Meir
    Brown, Cara
    Cheung, Amy
    Dawson, Hiltrud
    Rector, Neil
    Guenette, Melanie
    Richter, Margaret
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2020, 65 (12): : 821 - 834
  • [4] Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis
    Ye, Wenrui
    Luo, Cong
    Huang, Jing
    Li, Chenglong
    Liu, Zhixiong
    Liu, Fangkun
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [5] EXPOSURE TO ARTEMISININS IN PREGNANCY AND THE RISK OF ADVERSE PREGNANCY OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Kovacs, Stephanie D.
    van Eijk, Annemieke
    Dellicour, Stephanie
    Sevene, Esperanca
    Tinto, Halidou
    D'Alessandro, Umberto
    ter Kuile, Feiko
    Stergachis, Andy
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 257 - 257
  • [6] Association between maternal exposure to perfluoroalkyl and polyfluoroalkyl substances and risks of adverse pregnancy outcomes: A systematic review and meta-analysis
    Deji, Zhuoma
    Liu, Peng
    Wang, Xin
    Zhang, Xin
    Luo, Yuehua
    Huang, Zhenzhen
    SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 783
  • [7] Association between maternal exposure to perfluoroalkyl and polyfluoroalkyl substances and risks of adverse pregnancy outcomes: A systematic review and meta-analysis
    Gnansia, Elisabeth
    ENVIRONNEMENT RISQUES & SANTE, 2021, 20 (06): : 577 - 578
  • [8] The association between bacteriuria and adverse pregnancy outcomes: a systematic review and meta-analysis of observational studies
    Piazzolla, Hans R. W.
    Modin, Frederikke
    Halkjaer, Sofie, I
    Petersen, Andreas M.
    Calum, Henrik
    Holm, Anne
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (02) : 241 - 254
  • [9] Maternal exposure to sulfonamides and adverse pregnancy outcomes: A systematic review and meta-analysis
    Li, Peixuan
    Qin, Xiaoyun
    Tao, Fangbiao
    Huang, Kun
    PLOS ONE, 2020, 15 (12):
  • [10] Adverse pregnancy outcomes in gestational diabetes mellitus: a systematic review and meta-analysis protocol
    Chukwuemeka, Scholarstica
    Chivese, Tawanda
    Gopinath, Aswathy
    Obikeze, Kenechukwu
    BMJ OPEN, 2024, 14 (05): : 1 - 4